You can buy or sell CORT and other stocks, options, ETFs, and crypto commission-free!
Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Read More Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Menlo Park, California
52 Week High
52 Week Low
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
NEW YORK, NY / ACCESSWIRE / March 26, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (''Corcept'' or the ''Company'') (CORT). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Corcept Therapeutics Incorporated to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Corcept Therapeutics Incorporated ("Corcept" or the "Company")(CORT) of the May 13, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Corcept stock or options between August 2, 2017 and February 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CORT. There is no cost or...
Hagens Berman Reminds Corcept Therapeutics (NASDAQ: CORT) Investors of May 13, 2019 Lead Plaintiff Deadline
SAN FRANCISCO, March 26, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Corcept Therapeutics Incorporated (CORT) of the May 13, 2019 Lead Plaintiff deadline in the pending securities class action.
Expected May 7, After Hours